- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Methodological Effects on the Measurement of Repeat HospitalizationsThe rates of potentially preventable readmissions vary across measurement methodologies which explains inconsistencies in previous studies. Results suggest measurement of readmissions incentivizes inefficient behavior.
Latest:
Impact of a Program Encouraging the Use of Generic AntipsychoticsAcademic detailing coupled with a provider survey did not decrease the rate of new prescriptions for costly, on-patent second-generation antipsychotics in a VA hospital.
Latest:
Are Obese Patients Assisted in Losing Weight?In obese patients, we assessed the lack of advice to lose weight and its association with cardiovascular risk using the REGICOR chart (adaption of Framingham).
Latest:
Cost and Utilization Avoidance With Mail Prompts: A Randomized Controlled TrialBy mailing information to their members, health plans can affect rates of medical service utilization and generate cost savings.
Latest:
Non–Face-to-Face Care Management and Service Utilization in Patients With DiabetesCMS began reimbursement for non–face-to-face chronic care management in 2015, and results from Louisiana show that it increases outpatient visits but decreases inpatient and emergency department encounters.
Latest:
A Transitional Care Model for Patients With Acute Coronary SyndromeThis study suggests that the Bridging the Discharge Gap Effectively (BRIDGE) program can help decrease the number of hospital readmissions in patients with acute coronary syndrome that cause unnecessary and substantial healthcare systems costs.
Latest:
TSI Assay Utilization: Impact on Costs of Graves' Hyperthyroidism DiagnosisAn evidence-based managed care budget impact model shows that incorporating TSI testing into existing Graves%u2019 disease hyperthyroidism diagnostic algorithms reduces costs and shortens time to diagnosis.
Latest:
Value-Based Pricing: The Role of Outcomes Data in Pricing ModelsData about escalating prices for cancer drugs laid the groundwork for the panel that followed, where Michael E. Chernew, PhD, Harvard health economist and co-editor-in-chief of The American Journal of Managed Care, outlined how changing the paradigm will require a different kind of shopping.
Latest:
Payer Coverage for Patients Enrolled Onto Clinical Trials: Making the Process Easy and Transparent for EveryoneIt is not just 1 physician who cares for a patient enrolled onto a clinical trial but rather a complex system of several physician teams, sometimes with very different opinions, who must work together for therapy to be successful and for the patient to have faith in his treating team.
Latest:
Predicting Nursing Home Placement Among Home- and Community-Based Services Program ParticipantsThe authors developed a model to identify participants in a home- and community-based services program who are at highest risk for long-term nursing home placement.
Latest:
Gender Differences in Prescribing of Zolpidem in the Veterans Health AdministrationWe found inappropriate prescribing of zolpidem, in terms of both guideline-discordant dosage and coprescribing with benzodiazepines, with female veterans affected more than male veterans.
Latest:
Hospital Cancer Pain Management by Electronic Health Record–Based Automatic ScreeningA cancer pain control program for inpatients based on electronic health record–based automatic screening provided effective pain relief and achieved high satisfaction among patients and physicians.
Latest:
Leveling the Field: Addressing Health Disparities Through Diabetes Disease ManagementA subanalysis of a successful algorithm-driven primary care–based diabetes disease management program examines the relationships among patient characteristics, labor inputs, and improvement in A1C level.
Latest:
Comparative Effectiveness Research: Challenges for Medical JournalsIn order to encourage dissemination, this commentary is freely available in PLoS Medicine, and will also be published in Medical Decision Making, Croatian Medical Journal, The Cochrane Library, Trials, and Journal of Clinical Epidemiology.
Latest:
Single- Versus Multiple-Tablet HIV Regimens: Adherence and Hospitalization RiskSingle-tablet regimens are associated with higher adherence rates, decreased hospitalizations, and a higher proportion of patients with undetectable viral load compared with multiple-tablet regimens in patients with HIV/AIDS.
Latest:
Case Study: How Does an ACO Generate Savings Three Years in a Row?Increasing accountable care organization savings is dependent on maximizing quality scores and increasing the number of beneficiaries while maintaining a low per-capita spend through efficiencies of care.
Latest:
Health Information Technology and Physicians' Perceptions of Healthcare QualityHealth information technology can enhance physicians' ability to provide high-quality care, suggesting that physicians should use it more extensively in their practices.
Latest:
Medical Home Effects on Enrollees With Mental and Physical IllnessMedical home enrollment had mixed effects on acute care use and a large effect on outpatient care use. Effects on expenditures varied by mental illness.
Latest:
Tools to Gauge Progress During Patient-Centered Medical Home TransformationWe reviewed operational details and content of tools designed to evaluate patient-centered medical home (PCMH) transformation. These tools assist practice leaders in understanding specific information about the process and progress of becoming a PCMH.
Latest:
Organizational Capacity Among Hospitals in Medicare and Commercial Bundled PaymentsA national survey demonstrated differences in organizational capacity between hospitals participating in Medicare bundled payment programs and those coparticipating in both Medicare and commercial bundled payment programs.
Latest:
Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent ParticipantsOver 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
